| CAR-T regulatory (CAR-Treg) cells: engineering and applications M Arjomandnejad, AL Kopec, AM Keeler Biomedicines 10 (2), 287, 2022 | 80 | 2022 |
| Immunogenicity of recombinant adeno-associated virus (AAV) vectors for gene transfer M Arjomandnejad, I Dasgupta, TR Flotte, AM Keeler BioDrugs 37 (3), 311-329, 2023 | 74 | 2023 |
| Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells M Arjomandnejad, K Sylvia, M Blackwood, T Nixon, Q Tang, M Muhuri, ... Molecular Therapy Methods & Clinical Development 23, 490-506, 2021 | 32 | 2021 |
| Novel combinatorial microRNA-binding sites in AAV vectors synergistically diminish antigen presentation and transgene immunity for efficient and stable transduction M Muhuri, W Zhan, Y Maeda, J Li, A Lotun, J Chen, K Sylvia, I Dasgupta, ... Frontiers in immunology 12, 674242, 2021 | 30 | 2021 |
| HeLa cell line xenograft tumor as a suitable cervical cancer model: growth kinetic characterization and immunohistochemistry array M Arjomandnejad, A Muhammadnejad, M Haddadi, N Sherkat-Khameneh, ... Archives of Iranian Medicine 17 (4), 0-0, 2014 | 24 | 2014 |
| AGS cell line xenograft tumor as a suitable gastric adenocarcinoma model: growth kinetic characterization and immunohistochemistry analysis T Barati, M Haddadi, F Sadeghi, S Muhammadnejad, A Muhammadnejad, ... Iranian Journal of Basic Medical Sciences 21 (7), 678, 2018 | 7 | 2018 |
| Redosing adeno-associated virus gene therapy to the central nervous system A McElroy, M Sena-Esteves, M Arjomandnejad, AM Keeler, ... Human Gene Therapy 33 (17-18), 889-892, 2022 | 6 | 2022 |
| CAR-T regulatory (CAR-Treg) cells: engineering and applications. Biomedicines 10, 287 M Arjomandnejad, AL Kopec, AM Keeler | 5 | 2022 |
| Evaluating Readministration of Adeno-Associated Virus for Gene Therapy. M Arjomandnejad, AM Keeler Human Gene Therapy 33 (5-6), 218-220, 2022 | 2 | 2022 |
| CAR-T regulatory (CAR-Treg) cells: engineering and applications. Biomedicines 2022; 10: 287 M Arjomandnejad, AL Kopec, AM Keeler s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | 1 | 2022 |
| Feasibility assessment of in vitro chemoresponse assay on stereotactic biopsies of glioblastoma multiforms: a step towards personalized medicine FS Fazel, M Haddadi, A Khoshnevisan, S Muhammadnejad, ... Iranian Journal of Basic Medical Sciences 17 (11), 922, 2014 | 1 | 2014 |
| Comparative spatial transcriptomics of hair follicle-T cell interactions in mouse, dog and human reveals conserved drivers of primary cicatricial alopecia U Yildiz-Altay, R Adhanom, W Abdi, A Romasco, L You, E Santacruz, ... bioRxiv, 2025.01. 20.633953, 2025 | | 2025 |
| Aav capsid chimeric antigen receptors and uses thereof A Keeler-Klunk, T Flotte, M Arjomandnejad US Patent App. 17/605,615, 2022 | | 2022 |
| Tropism of AAV-rh32. 33 for Skin Endothelial Cells and Fibroblasts M Arjomandnejad, K Sylvia, E Katz, Q Tang, J Harris, AM Keeler MOLECULAR THERAPY 30 (4), 254-254, 2022 | | 2022 |
| AAV Specific CAR Regulatory T Cells Mitigate Immune Responses against AAV Gene Therapy M Arjomandnejad, T Nixon, Q Tang, M Blackwood, K Sylvia, ... MOLECULAR THERAPY 29 (4), 90-91, 2021 | | 2021 |
| Creating AAV Specific CAR T-Cells and CAR Regulatory T-Cells to Model and Mitigate AAV Immune Responses M Arjomandnejad, K Sylvia, Q Tang, AM Gruntman, AM Keeler, G Gao, ... MOLECULAR THERAPY 28 (4), 414-414, 2020 | | 2020 |
| THREE DIMENSIONAL MODELING OF ANTI-MUC-1 VHH WITH BIOINFORMATICS METHODS M Ganji, F RAHBARIZADEH, M ARJOMANDNEJAD | | 2017 |
Allison M KeelerAssistant ProfessorAdresse e-mail validée de umassmed.edu